AngioDynamics
ANGO
167 hedge funds and large institutions have $577M invested in AngioDynamics in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 91 increasing their positions, 33 reducing their positions, and 13 closing their positions.
1,229% more call options, than puts
Call options by funds: $319K | Put options by funds: $24K
176% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 33
38% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 13
12.03% more ownership
Funds ownership: 84.73% → 96.76% (+12%)
6% more capital invested
Capital invested by funds: $546M → $577M (+$30.9M)
2% more funds holding
Funds holding: 163 → 167 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$15.2M |
| 2 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$11.8M |
| 3 |
BlackRock
New York
|
+$8.35M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$7.44M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$6.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGH
Partners Group Holding
Baar-Zug,
Switzerland
|
-$5.76M |
| 2 |
JP Morgan Chase
New York
|
-$4.83M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.01M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$2.99M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.69M |
ANGO Hedge Fund Activity: Q2 2017 in Review
167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2017, worth a combined $577M — up 5.7% from $546M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ANGO positions and 13 closed out — a net gain of 5 holders — while 91 added to existing stakes and 33 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $15.2M. The largest seller was Partners Group Holding, exiting entirely with an estimated $5.76M sold.
- 167 institutional investors held AngioDynamics (ANGO) as of Q2 2017, up from 163 in Q1 2017.
- Funds reported $577M of AngioDynamics stock for Q2 2017, up 5.7% quarter-over-quarter.
- 18 funds opened new AngioDynamics positions in Q2 2017 and 13 closed out, a net change of +5 holders.
- The largest AngioDynamics buyer in Q2 2017 was Janus Henderson Group, an estimated $15.2M added.
- The largest AngioDynamics seller in Q2 2017 was Partners Group Holding, an estimated $5.76M sold.
Based on aggregated 13F filings for Q2 2017.